A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan

Hepatology International

Volumn 9, Issue 3, 2015, Pages 378-390

  Bennett, Heather ^a   Waser, Nathalie ^a   Johnston, Karissa ^a   Kao, Jia Horng ^b   Lim, Young Suk ^c   Duan, Zhong Ping ^d   Lee, Youn Jae ^e   Wei, Lai ^f   Chen, Chien Jen ^g   Sievert, William ^h   Yuan, Yong ⁱ   Li, Hong ⁱ  

^a ICON PLC   (United Kingdom)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Asan Medical Center   (South Korea)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e Inje University College of Medicine   (South Korea)

^f PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^h MONASH UNIVERSITY   (Australia)

ⁱ BRISTOL MYERS SQUIBB   (United States)

Author keywords

Complications of HCV infection; Epidemiology; Genotype; Hepatitis C virus; Incidence; Prevalence

Indexed keywords

AGE DISTRIBUTION; ASCITES; BLOOD DONOR; BODY MASS; CHINA; COMORBIDITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; ESOPHAGUS VARICES; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HEPATITIS C VIRUS SUBTYPE 1B; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; INTRAVENOUS DRUG ABUSE; JAPAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MIXED INFECTION; MORTALITY; NONHUMAN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEX DIFFERENCE; SOUTH KOREA; SURVIVAL RATE; SYSTEMATIC REVIEW; TAIWAN; COMPLICATION; COST OF ILLNESS;

CHINA; COST OF ILLNESS; HEPATITIS C; HUMANS; INCIDENCE; JAPAN; PREVALENCE; REPUBLIC OF KOREA; TAIWAN;

EID: 84931570272     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-015-9629-x     Document Type: Review

References (48)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41–52
2. Hanafiah KM, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatol 2013;57:1333–1342
3. Sievert W, Altraif I, Razavi HA, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011;31:61–80
4. Yan Z, Fan K, Wang Y, et al. Changing pattern of clinical epidemiology on hepatitis C virus infection in Southwest China. Hepat Mon 2012;12:196–204
5. Hu Y, Yu C, Chen B, Wang L. Implication of reported viral hepatitis incidence rate change in Hubei Province, China, between 2004–2010. J Huazhong Univ Sci Technol 2012;32:428–433
6. Global Burden of Hepatitis C Working Group. J Clin Pharmacol 2004;44:20–29
7. Li D, Long Y, Wang T, et al. Epidemiology of hepatitis C virus infection in highly endemic HBV areas in China. PLoS ONE 2013;8:1–6
8. Lu W-P, Lin G-X, Shi S, Dong J-H. Simultaneously high prevalences of hepatitis B and C virus infections in a population in Putian County, China. J Clin Microbiol 2012;50:2142–2144
9. Katayama K, Matsuo J, Akita T, et al. Report of questionnaire survey about the rate of having hepatitis screening and the prevalence of hepatitis virus infection among the general population and the working population. Kanzo 2012;53:707–720
10. Miyazaki T, Honda A, Ikegami T, et al. Hepatitis C virus infection causes hypolipidemia regardless of hepatic damage or nutritional state: an epidemiological survey of a large Japanese cohort. Hepatol Res 2011;41:530–541
11. Kim DY, Kim IH, Jeong S-H, et al. A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver Int 2013;33:586–594
12. Chung SD, Keller JJ, Liang YC, Lin HC. Association between viral hepatitis and erectile dysfunction: a population-based case-control analysis. J Sex Med 2012;9:1295–1302
13. Lee M-H, Yang H-I, Jen C-L, et al. Community and personal risk factors for hepatitis C virus infection: a survey of 23 820 residents in Taiwan in 1991–1992. Gut 2011;60:688–694
14. Wu S, Wu F, Hong R, He J. Incidence analyses and space-time cluster detection of hepatitis C in Fujian Province of China from 2006 to 2010. PLoS ONE 2012;7:1–7
15. Dong R, Qiao X, Jia W, et al. HIV, HCV, and HBV co-infections in a rural area of Shanxi Province with a history of commercial blood donation. Biomed Environ Sci 2011;24:207–213
16. Tanaka J, Koyama T, Mizui M, et al. Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale. Intervirol 2011;54:185–195
17. Yuan J, Yang Y, Han F, et al. Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus. Hepatobiliary Pancreat Dis Int 2012;11:302–306
18. Wang X, Norris JL, Liu Y, et al. Health-related attitudes and risk factors for sexually transmitted infections of Chinese women who have sex with women. Chin Med J 2012;125:2819–2825
19. Fu Y, Qin W, Cao H, et al. HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLoS ONE 2012;7:1–11
20. Wu N, Ge Q, Feng Q, et al. High prevalence of Hepatitis C virus among injection drug users in Zhenjiang, Jiangsu, China. Indian J Virol 2011;22:77–83
21. Du J, Wang Z, Xie B, Zhao M. Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai. China. Am J Drug Alcohol Abuse 2012;38:228–232
22. Wang X, Tan L, Li Y, et al. HCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, China. PLoS ONE 2012;7:1–5
23. Hser Y, Du J, Li J, et al. Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China. J Public Health 2012;34:24–31
24. He N, Chen L, Lin HJ, et al. Multiple viral coinfections among HIV/AIDS patients in China. Biosci Trend 2011;5:1–9
25. Yan YX, Gao YQ, Sun X, et al. Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients. Epidemiol Infect 2011;139:354–360
26. Pan X, Zhu Y, Wang Q, et al. Prevalence of HIV, syphilis, HCV and their high risk behaviours among migrant workers in Eastern China. PLoS ONE 2013;8:1–9
27. Yan J, Kanda T, Wu S, et al. Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan. Hepatol Res 2012;42:974–981
28. Nagao Y, Sata M. A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: association study with mutations in the core and NS5A region of hepatitis C virus. BMC Gastroenterol 2012;12:1–8
29. Min J-A, Yoon Y, Lee HJ, et al. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea. J Med Virol 2013;85:575–582
30. Kang J, Cho JH, Suh CW, et al. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol 2011;90:159–164
31. Tseng Y-T, Sun H-Y, Chang S-Y, et al. Seroprevalence of hepatitis virus infection in men who have sex with men aged 18–40 years in Taiwan. J Formos Med Assoc 2012;111:431–438
32. Liao K-F, Lai S-W, Lin C-Y, et al. Diversity of hepatitis C virus genotypes among intravenous heroin users in Taiwan. Am J Med Sci 2011;341:110–112
33. Hung C-C, Loh E-W, Hu T-M, et al. Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions. J Chin Med Assoc 2012;75:275–280
34. Yu S-C, Lin C-W. Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection. Kaohsiung J Med Sci 2013;29:150–156
35. Rao H, Wei L, Lopez-Talavera JC, et al. Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2014;29:545–553
36. Wang C, Cai WP, Tucker J, et al. Hepatitis C Epidemiology in HCV Mono-infected and HIV/HCV Co-infected Subjects from Guangzhou, China. In 1st Asian conference on hepatitis B and C, HIV and influenza, 18–19 May, Beijing, China 2012
37. Wang C. Epidemiology of HCV and HIV/HCV Infection in Guangzhou, China. Presentation, University of North Carolina at Chapel Hill 2013
38. Lee MH, Yang HI, Lu SN, et al. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma. Int J Cancer 2014;135:1119–1126
39. Yatsuji S, Hashimoto E, Tobari M, et al. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol 2009;24:248–254
40. Kim ET, Kim LH, Lee JI, Chin HS. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin. Jpn J Ophthalmol 2009;53:598–602
41. Huang JF, Chuang WL, Yu ML, et al. Hepatitis C virus infection and metabolic syndrome—a community-based study in an endemic area of Taiwan. Kaohsiung J Med Sci 2009;25:299–305
42. Yotsuyanagi H, Kikuchi Y, Tsukada K, et al. Chronic hepatitis C in patients co-infected with human immunodeficiency virus in Japan: a retrospective multicenter analysis. Hepatol Res 2009;39:657–663
43. Lee M-H, Yang H-I, Chen C-J, et al. Long-term health outcomes of chronic hepatitis C patients: a review of findings from REVEAL-HCV cohort study. BioMed (Netherlands) 2012;2(3):99–107
44. Hu Z, Zhou J, Wang H, et al. Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010. PLoS ONE 2013;8:e61620
45. Qin Q, Smith MK, Wang L, et al. Hepatitis C virus infection in China: an emerging public health issue. J Viral Hepat 2015;22(3):238–244
46. World Health Organization, Guidelines Development Group. Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection. World Health Organization 2014 Accessed: 2014 Aug 20; Available at: http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/
47. Lee MH, Yang HI, Yuan Y, et al. Epidemiology and natural history of hepatitis C virus infection. World J Gastroenterol 2014;20:9270–9280
48. Shin A, Cho ER, Kim J, et al. Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea. Cancer Epidemiol Biomarkers Prev 2009;18:1894–1898